Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

Assessing interactions between mdm-2, p53, and bcl-2 as prognostic variables in muscle-invasive bladder cancer treated with neo-adjuvant chemotherapy followed by locoregional surgical treatment.

Maluf FC, Cordon-Cardo C, Verbel DA, Satagopan JM, Boyle MG, Herr H, Bajorin DF.

Ann Oncol. 2006 Nov;17(11):1677-86. Epub 2006 Sep 19.

PMID:
16984978
2.

Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma.

Manne U, Myers RB, Moron C, Poczatek RB, Dillard S, Weiss H, Brown D, Srivastava S, Grizzle WE.

Int J Cancer. 1997 Jun 20;74(3):346-58. Review.

3.

Outcomes and response to therapy in bladder cancer. Are biomarkers of any help?

Goebell PJ.

Minerva Urol Nefrol. 2009 Jun;61(2):91-107. Review.

PMID:
19451891
4.

The role of MDM2 and MDM4 in breast cancer development and prevention.

Haupt S, Vijayakumaran R, Miranda PJ, Burgess A, Lim E, Haupt Y.

J Mol Cell Biol. 2017 Feb 1;9(1):53-61. doi: 10.1093/jmcb/mjx007. Review.

Supplemental Content

Support Center